Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fourth Annual In Vino Vita Wine Auction Supports Research and Patient Care at Fox Chase Cancer Center
PHILADELPHIA (March 23, 2017) — Fox Chase Cancer Center will present its signature fundraising event In Vino Vita Benefit and Wine Auction on Saturday, April 22, 2017 at Vie.
Now in its fourth year, In Vino Vita has raised nearly $2 million and evolved into a premier wine event in Philadelphia. This year, some of the world’s finest winemaking talent will be participating in the event, including Fisher Vineyards, Paul Hobbs Wines, Retour Winery and Laurent-Perrier Champagne.
In keeping with its name, meaning “In Wine, Life,” the event raises money for pioneering research and patient care at Fox Chase. While enjoying an evening of live music and a multi-course dinner, guests participate in a lively auction with high-end wine and related experiences available to the highest bidders. More than 450 prominent healthcare, business, and philanthropic leaders attended the 2016 event.
One of the hallmarks of In Vino Vita is the Special Pledge, in which attendees band together to support a worthwhile project at Fox Chase. This year the Special Pledge will focus on pilot funding for early stage research. Pilot funding is seed money that enables initial testing of innovative theories, and helps researchers collect and sometimes publish preliminary findings, which is often necessary to secure larger grants. Funding at this stage can be the difference between a study happening or not happening. Previous Special Pledges brought upgraded infusion room patient chairs, an expansion and comprehensive renovation of the surgical family waiting suite, and a state-of-the-art immunotherapy lab.
Tickets are available at vinovita.org.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427